Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical is applying for assessing Cytoparin as drug in upcoming clinical study

Oct 1 (Reuters) - Corline Biomedical AB  CLBIO.ST : 
    * Says is applying for assessing Cytoparin as drug in upcoming clinical study 
    * H2 2016 is scheduled time for reporting results of first clinical study of Cytoparin  
 
 
 
Source text for Eikon:  ID:nHUG4xnZbD  
     
Further company coverage:  CLBIO.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Corline Biomedical AB

See all news